Period Ending | Jun 29, 2012 | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 |
---|
Total Revenue
|
13,349,000
|
13,136,000
|
14,166,000
|
13,166,000
| Cost of Revenue | 3,263,000 | 3,281,000 | 3,650,000 | 3,364,000 | |
Gross Profit
|
10,086,000
|
9,855,000
|
10,516,000
|
9,802,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 7,837,000 | 7,827,000 | 8,728,000 | 7,829,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 459,000 | 459,000 | 451,000 | 447,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,790,000
|
1,569,000
|
1,337,000
|
1,526,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 6,000 | 6,000 | 8,000 | 16,000 |
|
Earnings Before Interest And Taxes | 1,796,000 | 1,575,000 | 1,345,000 | 1,542,000 |
|
Interest Expense | 92,000 | 94,000 | 96,000 | 84,000 |
|
Income Before Tax | 1,704,000 | 1,481,000 | 1,249,000 | 1,458,000 |
|
Income Tax Expense | 588,000 | 511,000 | 435,000 | 475,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,116,000 | 970,000 | 814,000 | 983,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,116,000
|
970,000
|
814,000
|
983,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,116,000
|
970,000
|
814,000
|
983,000
|
|